Previous studies have shown that the initial interaction of herpes simplex virus (HSV) with cells is binding to heparan sulphate and that HSV-1 glycoprotein C (gC) is principally responsible for this binding. Although gCnegative viral mutants are impaired for binding and entry, they retain significant infectivity. The purpose of the studies reported here was to explore the requirements for infectivity of gC-negative HSV-1 mutants. We found that absence or alteration of cell surface heparan sulphate significantly reduced the binding ofgC-negative mutant virus and rendered cells resistant to infection, as shown previously for the wild-type virus. We isolated a recombinant double-mutated HSV strain that produces virions devoid of both of the known heparin-binding glycoproteins, gB and gC. The drastically impaired binding of these mutant virions to cells, relative to gCnegative and wild-type virions, indicates that gB mediates the binding of gC-negative virions to cells. Thus at least two HSV glycoproteins can independently mediate the binding of HSV to cell surface heparan sulphate to start the process of viral entry into cells.
Introduction
Herpes simplex viruses (HSV) infect a wide range of cells and can cause disease in a variety of different tissues and in different animal species. This relatively broad host range suggests that cell receptors for HSV must be common to many different cell types and/or that there may be more than one pathway by which the virus can enter a cell. Moreover, the envelope of the HSV virion contains at least 10 different viral glycoproteins (Spear, 1993) , several of which project as distinct spikes from the membrane surface (Stannard et al., 1987) . Therefore it seems possible that binding of the virus to a cell and the subsequent steps leading to virion-cell fusion may require sequential or simultaneous interactions of multiple virion proteins with several different sites or receptors on the cell surface.
The process of viral entry can be divided into two distinct phases: binding, the attachment of viral particles to the cell surface and penetration, the entry of the nucleocapsid into the cell cytoplasm. These two processes can be dissociated from one another at low temperature or by neutralizing antibodies that block penetration, but not binding (Fuller et at., 1989; Highlander et al., 1987 Highlander et al., , 1988 . For a variety of cell types, binding can be mediated by interaction of the viral envelope glycoprotein C (gC) with heparan sulphate glycosaminoglycans (Campadelli-Fiume et al., 1990; Herold et al., 1991; Shieh et al., 1992; WuDunn & Spear, 1989) . Penetration occurs by fusion of the virion envelope with the cell plasma membrane (Fuller et al., 1989; Koyana & Uchida, 1984; Morgan et al., 1968; Para et al., 1980; Wittels & Spear, 1991) . This requires the activities of at least four glycoproteins, designated gB, gD, gH and gL Desai et al., 1988; Forrester et al., 1992; Roop et al., 1993; Ligas & Johnson, 1988; Little et al., 1981 ; Sarmiento et al., 1979) .
For several alphaherpesviruses, including HSV-1, pseudorabies virus (PRV) and bovine herpesvirus type 1 (BHV-1), the process of viral binding to ceils appears to be quite similar (Spear, 1993) . For all three viruses, the principal component of the initial binding of virion to the cell surface is interaction of a member of the gC family with heparan sulphate. Evidence for this includes the following. (i) These viruses exhibit greatly reduced binding to cells that are deficient in heparan sulphate, regardless of whether this deficiency is due to enzymatic treatment (for example with heparinase or heparitinase) or genetic mutation (Gruenheid et al., 1993 ; Mettenleiter et al., 1990; Okazaki et al., 1991; Shieh et al., 1992; WuDunn & Spear, 1989) . (ii) Heparin, which is structurally very similar to heparan sulphate, inhibits the binding of the virus to cells (Baba et al., 1988; Mettenleiter et at., 1990; Okazaki et al., 1991 ; Sheih et at., 1992; Herold et al., 1991 ; WuDunn & Spear, 1989) . (iii) Virions bind to heparin affinity columns in physiological saline (Mettenleiter et al., 1990; Okazaki et al., 1991; Herold et al., 1991) . (iv) Deletion of the gCcoding genes of HSV-1, PRV or BHV-1 results in mutants that are significantly impaired in their ability to bind to cells (Herold et al., 1991; Liang et at., 1991a; Schreurs et al., 1988; Zuckermann et al., 1989) . (v) The gC homologues all bind to heparin affinity columns in physiological saline (Herold et al., 1991; Mettenleiter et al., 1990; Okazaki et al., 1991 ; Sawitzky et al., 1990) . (vi) Neutralizing antibodies specific for the gC of HSV-1, PRV or BHV-1 can block the binding of virus to cells (Fuller & Spear, 1985; Okazaki et al., 1986; Schreurs et at., 1988; Svennerholm et al., 1991) , whereas most neutralizing antibodies specific for other glycoproteins act by blocking viral penetration. It is not clear whether the interaction of gC with heparan sulphate is sufficient to mediate stable binding of virus to cells, or whether optimum binding requires additional virion-cell interactions. For example there is evidence that gD may interact with its own cell surface receptor, subsequent to the initial binding of the virus to a cell. Binding of inactivated, wild-type HSV to cells inhibits the subsequent penetration, but not the binding, of homologous challenge virus, whereas gD-negative virions bind to cells but fail to inhibit penetration of challenge virus (Johnson & Ligas, 1988) . Moreover a truncated, soluble form of gD binds to cells and can inhibit HSV entry, but not virus binding to cells (Johnson et al., 1990) .
Although mutants of HSV-1, PRV or BHV-1 that fail to express gC are impaired in their ability to bind to and infect cells, they are still infectious (Herold et al., 1991; Liang et al., 1991a; Schreurs et al., 1988) . Therefore, in addition to the gC-mediated mode of binding, there must also be a gC-independent mode. The latter may be completely distinct from the normal pathway of infection, occurring only when gC is absent. Alternatively this mode of binding may actually represent a subset of the normal interactions that occur at the cell surface during wild-type viral infection. For example, the initial interaction of gC with heparan sulphate proteoglycans at the cell surface (which is not absolutely required for infectivity) may facilitate subsequent virion-cell interactions that are essential for viral entry. The binding of gC to heparan sulphate might serve to concentrate virus at the cell surface or might induce a conformational change, either in a virion component or in a cell component or both, that enhances subsequent virion-cell interaction(s). Determination of the gC-independent mode of attachment may therefore allow us to uncover other potential receptor-ligand interactions that occur prior to penetration, not only when gC is absent, but perhaps during wild-type viral infection. These studies were designed to define the requirements for binding of gC-negative viruses to cells. We have found that gCnegative viruses interact with heparan sulphate, and that gB appears to be the ligand for this receptor when gC is absent.
Methods
Celts and viruses. HEp-2 human laryngeal carcinoma cells and the African green monkey-derived Vero cell line were obtained from the ATCC. The VeroB24 cell line, which carries a functional gene for HSV-I gB and was used for the propagation of a gB-negative mutant, has previously been described (Herold et al., 1991) . The HEp-2 and VeroB24 cells were passaged in Dulbecco's modified Eagle's medium supplemented with 10 % fetal bovine serum (FBS). The Vero cells were passaged in medium 199 supplemented with 5 % bovine serum. Wildtype Chinese hamster ovary (CHO)-K1 cells and glycosaminoglycandeficient CHO mutants have been previously described (Esko, 1991; Esko et al., 1985; Shieh et al., 1992) and were obtained from J. D. Esko (University of Alabama, Birmingham, Ala., U.S.A.). The CHO cells were passaged in Ham's F12 medium supplemented with 10% FBS.
The virus strains used in this study are listed in Table 1 . Two samples of wild-type HSV-I(KOS), which had been maintained in different laboratories, were passaged prior to use. They were assumed to be equivalent and no differences in any of the phenotypes assessed were noted. All experiments performed with HSV-1AgC2-3 or HSV-lgC2-3Rev (abbreviated to Rev) included controls with the HSV-I(KOS) strain obtained from S. Read (Table 1) because this was the parental strain from which the mutants were derived. Viable strains of HSV were propagated in HEp-2 cells, whereas the double-negative and gBnegative viruses were propagated in VeroB24 cells. One passage of the gB-negative or the double-negative virus through non-permissive cells yields virions devoid of gB or gB and gC respectively.
Plasmids and bacteria. The plasmid pON245 was provided by E. Mocarski (Stanford University, Stanford, Calif., U.S.A.). This plasmid contains the Escherichia coli lacZ gene transcribed from the HSV-1 thymidine kinase (TK) gene promoter, the simian virus 40 poly(A) sequence for proper termination of the lacZ transcript, and the pBR322 ampicillin resistance gene and origin of replication. Digestion of pON245 with BamHI gives a 4.4 kb fragment containing the TK-lacZ cassette. The plasmid pUC19 was used to clone genes from the HSV-I(KOS) genome. Isolation and purification of plasmid DNA were performed using the alkaline lysis method (Maniatis et al., 1982) . All recombinant plasmids were produced in E. coli strain HB101. All enzymes for cloning were obtained from either Boehringer Mannheiln or Promega, and were used according to the specifications of the manufacturers. (Graham & van der Eb, 1973) . Recombinant progeny were identified as blue plaque variants using the chromogenic substrate X-gal as previously described (Goldstein & Weber, 1988) . One such recombinant was plaque-purified and designated HSV1AgC2-3. A revertant ofHSV-1AgC2-3, Rev, was obtained by repeating the marker transfer experiment using HSV-1 AgC2-3 viral DNA and the wild-type gC gene. Revertants were isolated by screening the resulting progeny for white plaques in the presence of X-gal. The viral genomes were analysed by restriction endonuclease digestion and electrophoresis, using purified DNAs in ethidium bromide-stained gels or by Southern blot analysis. Procedures for agarose gel electrophoresis, transfer of DNA to nitrocellulose, 3~P-labelling of DNA probes by nick translation and hybridization have been described elsewhere (Brandt & Grau, 1990) .
Isolation of a gB-negative, gC-negative recombinant virus. A doublenegative recombinant strain of HSV was generated by co-infecting VeroB24 cells in 75 cm 2 flasks with KO82 (gB-negative) and gC-3 (gCnegative) viruses (5 p.f.u, of each virus per cell). After 20 h, the infected cells were harvested and the resulting stock was used to screen for the desired recombinants in VeroB24 cells. Progeny plaques that were gCnegative were identified using an immunoassay with a monoclonal antibody, II-73, specific for gC (Para et al., 1985) . Progeny from individual gC-negative plaques were subsequently screened for the gBnegative phenotype by differential plating on Vero and VeroB24 cells. Clones with reduced infectivity on Vero cells were selected and virus was obtained from isolated plaques on the VeroB24 cells. This process of mutant identification and plaque purification was repeated three times. A working stock was prepared in VeroB24 cells. The phenotype was confirmed by purifying virus produced in non-complementing Vero cells and performing a Western blot using polyclonal antisera specific for gC and gB, as described below.
PAGE and Western blots. Purified virions were solubilized in SDS
sample buffer, boiled for 2 rain, and then loaded onto an 8.5% SDS~polyacrylamide gel (N,N'-diallyltartardiamide cross-linked). Following SDS PAGE, the proteins were transferred to nitrocellulose (Schleicher & Schuell) by Western transfer in 10 mM-Tris-150 mMglycine and 20 % methanol (Towbin et al., 1979) . Western blots were performed as previously described (Herold et al., 1991) . The antisera used were human anti-HSV-1 (Chemicon), rabbit anti-gB (R74; prepared in our laboratory) and rabbit anti-gC (obtained from J. Glorioso, University of Pittsburgh, Penn., U.S.A.).
Purification and quantification of virus. Virions were radiolabelled
with [3H]thymidine and purified from HEp-2 cells as previously described (Cassai et al., 1975; Herold et al., 1991) . For experiments involving the double-negative mutant, KOS, gC-3 and KO82xgC 3 were purified from Vero cells. For KOS and gC 3 viruses, the Veto cells were inoculated at an m.o.i, of 1 p.f.u./cell. Virus was harvested and purified on dextran gradients 48 h later. For KO82xgC-3, which produces non-infectious progeny on non-permissive cells, Vero cells were inoculated at an m.o.i, of 5 p.f.u./cell and virus was harvested after 18 h. The inoculnm was a virus stock produced on permissive VeroB24 cells and had a titre of about 108 p.f.u./ml on permissive VeroB24 cells and about 104 p.f.u./ml on non-permissive Vero cells. For the purified virion preparations, titres of infectious units were determined by plaque assays on Vero and VeroB24 cells and radioactivity was determined by liquid scintillation counting. Virions were quantified by directly counting particles using electron microscopy as previously described (Herold et al., 1991 ; Miller, 1982) . Prior to use, virus was diluted at a ratio of 1:5 (v/v) in PBS (10 mM-Na~HPO 4, 1.5 mM-KH2PO 4, 140 mM-NaC1, 2-5 mM-KC1, 0.5 mu-MgCl 2, 1 mMCaC12) and centrifuged at 25000 r.p.m, for 1 h in a Beckman 50Ti rotor to pellet the virus and separate it from the dextran. The pellet was resuspended in PBS.
Virus binding and infectivity assays.
Binding studies were performed directly at 4 °C in glass scintillation vials as previously described (Herold et al., 1991) . To assess the ability of soluble heparin to elute bound virus, the binding assay was modified, Purified, radiolabelled virions were allowed to bind to ceils for 4 h at 4 °C. The viral inoculum was removed and the cells were washed three times (final wash for 1 h) at 4 °C with heparin at various doses or with PBS as a control. The cellbound radioactivity was then quantified. Infectivity was determined by the levels of expression of an HSV immediate early gene, ICP4, as previously described (Shieh et al., 1992) .
Inhibitory agents and enzymatic treatment of cells'. Heparin (Sigma) was dissolved at the appropriate concentration in PBS. Heparitinase and heparinase (Sigma) digestions were performed in PBS with 0 1 % glucose, 0-1% BSA and 500 units of aprotinin per ml. Sodium chlorate was obtained from Mallinckrodt. In the experiments designed to test the effects of chlorate treatment of cells on viral infection, cells were incubated for 48 h prior to inoculation in MEM (Gibco) with modified, sulphate-deficient Earle's salts containing 86 mM-NaC1 and 30 mMNaC1Q, or 116 mr,~-NaC1 as a control. The cells were then inoculated with virus and an ICP4 expression assay was performed as previously described (Shieh et aL, 1992) .
Results

Properties of a new gC-negative mutant virus and an isogenic revertant strain
A gC-negative mutant, HSV-1AgC2-3, and a repaired revertant virus, Rev, were constructed from HSV-I(KOS). To confirm that HSV-1AgC2-3 contained the T K -l a c Z insert in place of the gC gene, DNA preparations from infected cells and virions were digested with either XbaI or HindIII and analysed by ethidium bromide staining of agarose gels and by Southern blot hybridization. Based on the predicted genome structures, digestion of HSV-1AgC2-3 DNA should yield a new fragment of 4.0 kbp with XbaI and new fragments of 5-3 kbp and 7-0 kbp with HindIII, when compared to KOS or Rev DNA. The predicted fragments were detected when digests of all three virus strains were analysed. In addition, Southern blots were also performed using either an EcoRI-HindIII (gC) probe (Fig.  2 a) or lacZ sequences (Fig. 2 b) . The gC and lacZ probes detected the 4"0 kbp XbaI band and the 5.3 kbp HindIII band in the HSV-1AgC2-3 lanes as expected. These probes did not hybridize to the 7-0 kbp HindIII fragment. The expected wild-type bands, over 20 kbp for XbaI and 8'7 kbp for HindIII, were detected for both KOS and Rev by the gC probe. No lacZ sequences were detected in these lanes (Fig. 2b) . These data are consistent with the expected genome structures shown in Fig. 1 . The gCexpression phenotype of the mutants was also confirmed using immunoprecipitations and Western blots (data not shown).
In a previous study, binding to cells and specific infectivity of a KOS gC-deficient mutant, gC 3, were shown to be impaired (Herold et al., 1991) . This mutant produces the entire ectodomain ofgC, but this is secreted rather than being incorporated into virions (Homa et al., 1986) . It was found that a similar mutant phenotype was exhibited by the gC-negative deletion mutant, HSV1AgC2-3. At equivalent concentrations of added virus, significantly fewer HSV-1AgC2-3 virions bound to HEp-2 cells, compared with both KOS and Rev, which bound to cells with similar efficiencies (data not shown). Specific infectivities for the strains were also determined on HEp-2 cells. The two gC-positive strains had comparable specific infectivities of 0'03 p.f.u./particle, whereas HSV1AgC2-3 had a specific infectivity of approximately 0.001 p.f.u./particle. This extends the previous work comparing KOS and gC 3 and supports the conclusion that the phenotype of inefficient binding and reduced infectivity for gC-negative strains can be accounted for by the absence of gC from the mutant virions. Most of the experiments described below (except those done with the double mutant recombinant virus) were carried out with both gC-negative mutants, gC-3 and HSV-1AgC2-3. Results obtained with only one mutant are shown because the phenotypes were indistinguishable. In addition, the repaired mutant virus, Rev, behaved like wildtype virus in all experiments.
Dependence on cell surface heparan sulphate for binding and infection by gC-negative HSV-1
In a previous study, we presented evidence that the binding and infectivity of the gC secretion mutant gC-3 was inhibited by soluble heparin (Herold et at., 1991) . This was also found to be true for the gC-negative strain HSV-1AgC2-3 and its revertant (data not shown). The finding that heparin inhibited the binding and infectivity of wild-type and gC-negative virus strains suggested that both viruses may interact with a heparin-like cell surface receptor. We used several approaches to modify cell surface heparan sulphate, in order to test the effects on the susceptibility of the cells to infection by KOS and HSV-1AgC2-3. First, we examined the susceptibility to infection by mutant and wild-type viruses of a panel of CHO cell lines defective in various aspects of glycosaminoglycan biosynthesis. CHO-K1 is a wild-type cell line that expresses normal levels of glycosaminoglycans and is susceptible to infection by HSV, although there is a wide range in the efficiency with which different HSV strains can initiate infection (Shieh et al., 1992) . The cell line pgsA-745 has a defect in the xylosyltransferase enzyme and produces little or no heparan sulphate or chondroitin sulphate (Esko et al., 1988) . The cell line pgsD-677 has a defect in N-acetylglucosaminyltransferase and glucuronosyltransferase and produces no heparan sulphate, but elevated levels of chondroitin sulphate (three times higher than in wild-type cells; Esko et al., 1985; Lidholt et al., 1992) . The cell line pgsE-606 has a defect in N-sulphotransferase. It produces normal levels of both heparan sulphate and chondroitin sulphate, but the heparan sulphate is undersulphated by a factor of two to three (Bame & Esko, 1989; Bame et al., 1991) . Shieh et al. (1992) have previously shown that the heparan sulphate-deficient CHO mutants are fully resistant to infection by KOS whereas the CHO mutant that produces undersulphated heparan sulphate is partially resistant.
Because CHO cells are not permissive for the full viral replicative cycle for most HSV strains, the ability of virus to infect CHO cells was assessed by quantifying the fraction of cells that expressed ICP4. Equivalent numbers of mutant and wild-type cells, grown on coverslips, were infected with various concentrations of KOS or HSV1AgC2-3. Relatively large amounts of KOS are required to infect CHO cells because these cells are not fully susceptible to infection by this strain of HSV-1.
The results obtained with the four CHO cell lines are shown in Fig. 3 . As expected, KOS infected a significant fraction of the wild-type CHO-K 1 cells but, at equivalent doses, failed to infect either of the cell lines pgsA-745 or pgsD-677, which are deficient in heparan sulphate biosynthesis. KOS also showed a reduced ability to infect the undersulphated pgsE-606 cell line. Similarly, at the highest dose of virus that could be tested, HSV-1AgC2-3 infected a smaller, but significant fraction of wild-type cells, but failed to infect the pgsA-745 cells or the pgsD-677 cells. The latter cell line expresses elevated levels of chondroitin sulphate. Therefore chondroitin sulphate cannot be a substitute receptor to any significant extent for KOS or HSV-1AgC2-3. Moreover, the gC-negative virus also had an impaired ability to infect the undersulphated pgsE-606 cell line. Binding of KOS and HSV1AgC2-3 to the mutant CHO cells was reduced, commensurate with the reductions in infection (data not shown), as previously shown for KOS (Shieh et al., 1992) .
Fully permissive HEp-2 cells were exposed to two different enzymes capable of digesting cell surface heparan sulphate. Heparinase cleaves glycosidic linkages in highly sulphated regions of the heparan sulphate chains, and heparitinase acts selectively on linkages in poorly sulphated regions. Digestion with either heparitinase or heparinase before virus adsorption resulted in a reduction in the number of plaques on the treated cells for both KOS and HSV-1AgC2-3 (Fig. 4) . The cells treated with heparinase were more resistant to HSV1AgC2-3 than to KOS. No differences in infectivity were noted with the heparitinase-treated cells. This suggests that binding or infectivity of gC-negative virus may be more dependent than that of wild-type virus on the highly sulphated regions of heparan sulphate. Similar effects were seen for viral binding although only 50 to 60 % of binding was inhibited for the two strains (data not shown).
To assess further the importance of glycosaminoglycan sulphation for viral infectivity, the effects of chlorate treatment of permissive HEp-2 cells on viral infection were examined. Sodium chlorate is an inhibitor of ATP sulphurylase, which is required for the production of phosphoadenosine phosphosulphate, the active sulphate donor for sulphotransferases. Sodium chlorate has been shown to inhibit sulphation of various glycosaminoglycans and proteins without inhibiting cell growth or protein synthesis (Keller et al., 1989) . For example, culturing cells with sodium chlorate has been shown to reduce the binding of basic fibroblast growth factor (bFGF) to heparan sulphate and its protein receptor (Rapraeger et al., 1991) . To determine whether blocking sulphation of cell surface glycosaminoglycans would reduce the susceptibility of treated cells to HSV infection, HEp-2 cells were grown in a sulphate-free medium in the presence of 30mM-sodium chlorate (or medium containing sodium chloride as a control) for 48 h prior to infection. The cells were then exposed to virus and infection was monitored by quantifying the percentage of cells expressing ICP4 (Fig. 5) to infect 50 % of cells was about 100-fold greater for the chlorate-treated cells than for control cells. This differential was probably even greater for HSV-1AgC2-3 but could not be quantified because of an inability to obtain virus preparations with higher titres. At the highest titre that could be prepared and tested, approximately 540 p.f.u./cell (the titre in untreated HEp-2 cells), fewer than 25 % of the chlorate-treated cells were infected by the gC-negative HSV-1AgC2-3 virus. This finding, coupled with the observations that the gC-negative virus infects the undersulphated C H O cell line and the heparinasetreated HEp-2 cells very poorly, suggests that gCnegative viruses may require a more highly sulphated subclass of heparan sulphate for infection. In other studies, it has been shown that the susceptibility of Veto or CHO-K1 cells to vesicular stomatitis virus is not affected by treatment of these cells with chlorate. In addition, the greater resistance of chlorate-treated cells to HSV infection can be attributed to the reduced binding of virus to cells (M. L. Parish, M.-T. Shieh & P. G. Spear, unpublished results) . were then studied to test whether one of these might mediate the binding of gC-negative virions to cells. The most likely candidate is gB since, like gC, it is a heparinbinding protein (Herold et al., 1991) . A gB-negative, gCnegative mutant strain of HSV, designated KO82xgC 3, was produced by isolating a recombinant of gC-3 and KO82 as described in Methods. Because gB is essential for viral penetration, studies with a double-negative mutant cannot include infectivity assays. A working Various concentrations of purified, radiolabelled virions were added to HEp-2 cells, which had been plated on the bottoms of glass scintillation vials. Binding was carried out for 5 h at 4 °C. After washing away unbound virus, scintillation fluid was added to the vials for the quantification of cell-bound radioactivity. The concentrations of added virions were determined by particle-counting under the electron microscope. The amount of bound virus was determined from the ratio of radioactivity to particle number in each virus preparation (8500 particles/c.p.m, for KOS, 7570 particles/c.p.m. for gC-3 and 6880 particles/c.p.m, for KO82xgC-3). Each point is the average of duplicate determinations. The duplicate values were within 10 % of each other. (A) KO82xgC-3 and (i) gC-3. Two dilution series of a single purified preparation of KOS were used to generate the two binding curves shown for KOS (O and C)). Three independent experiments were performed with similar results to compare the binding of KOS and the mutants. stock of double-negative mutant produced by VeroB24 cells had a titre of 2-4 x 108 p.f.u./ml on Vero B24 cells and 5"5 x 104 p.f.u./ml on Vero cells. This was because the complemented mutant virus, although equally infectious in VeroB24 and Vero cells, could not form plaques on Vero cells. One passage of KO82xgC 3 through Vero cells yielded uncomplemented mutant virions (preparations containing approximately 2 x 10 TM viral particles/ml and infectious titres of less than 10 a p.f.u./ml on both VeroB24 cells and Vero cells). The double-negative virus was purified from Vero cells, as were the control strains KOS and gC-3. The glycoprotein composition of each virus strain was characterized by Western blotting. To confirm the double-negative phenotype of the mutant, samples of purified KOS, gC-3 and KO82xgC-3 virus preparations were run on SDSpolyacrylamide gels, transferred to nitrocellulose, and probed with a human polyclonal anti-HSV-1 antiserum, a rabbit polyclonal anti-gB antiserum and a rabbit polyclonal anti-gC antiserum (Fig. 6) . The absence of gB or gC bands in the double-negative virus preparation could be caused by an inadequate quantity of virus. But other virus proteins were readily detected in the lane probed with polyclonal anti-HSV antiserum. Also, when blots of purified virus (4 x 108 particles/sample) were probed with a rabbit anti-gD antiserum along with the anti-gC and anti-gB antisera, comparable amounts of gD were detected in all virus preparations, but gB and/or gC could not be detected in the mutants (data not shown). These results confirm the double-negative phenotype of the recombinant mutant virus.
Binding of gC-negative HSV-1 to cells is gB-dependent
Binding studies with human HEp-2 cells were performed and the results are shown in Fig. 7 . Two previous studies Herold et al., 1991) have documented that virus strain KO82 is not impaired in its ability to bind to cells and therefore the data for this virus are not included. It was found, as has been previously shown (Herold et al., 1991) , that the gCnegative virus bound to cells less efficiently than did wildtype virus (Fig. 7) . The double-negative virus bound only marginally to HEp-2 cells and was impaired markedly compared with gC 3 and KOS at all virus levels tested. Even at the lowest concentration of virus (approximately 1500 particles/cell), 29 % of KOS virions and 13 % of gC-3 virions bound, but only 3 % of KO82xgC 3 virions did so. The marginal binding of the double-negative virus was comparable to the residual heparin-resistant binding seen for KOS. For example, at the highest doses of virus tested, soluble heparin at 0"1 mg/ml inhibited KOS binding by almost 90 %, to levels just below that of the double-negative virus. About 50 % of virus binding was heparin-sensitive for the double-negative virus. The severe impairment in binding to cells of the doublenegative virus, compared to the intermediate levels of binding of gC-negative virus supports the conclusion that gB mediates gC-independent binding. This is consistent with gC-independent binding being dependent on cell surface heparan sulphate, and with the previous finding that gB has an affinity for heparin-Sepharose (Herold et al., 1991) .
Virions that are gC-negative may bind with a higher avidity to cell surface heparan sulphate
We have previously found that both gC-positive and gCnegative virions bind stably to cell surfaces, and cannot be removed by simple washing (Herold et al., 1991; B. C. Herold & P. G. Spear, unpublished results) . To assess the avidity of wild-type and gC-negative virions for cell surface heparan sulphate, the ability of soluble heparin to elute bound virus was compared. Interestingly, after purified virions were allowed to bind to cells at 4 °C for 4 h, washes with soluble heparin eluted 60 % of bound wild-type virus, but only 20 % of bound gC- negative virus. If heparin (1 mg/ml) was present during the binding period, there was a 91% inhibition of wildtype virus binding compared to an 80 % inhibition of gC-negative viral binding. Thus, soluble heparin can efficiently inhibit the binding to cells of both wild-type and gC-negative virus, but once virus is bound, heparin elutes wild-type virus considerably more effectively than it elutes gC-negative virus.
Discussion
The initial attachment of HSV to a variety of cell types can be mediated independently by interactions of either gC or gB with cell surface heparan sulphate. For HEp-2 cells, when gC is present in the virion, the binding activity of gC predominates, and gB appears not to contribute significantly to initial viral attachment. For gC-negative viruses, gB plays the key role in the attachment of virus by interacting with the heparan sulphate moieties of cell surface proteoglycans. There are several potential roles for the interactions of gB with heparan sulphate that can be considered.
In certain circumstances gB may interact with heparan sulphate for viral binding. For example, this could occur when gC is absent from the virion, or when the specific structural features of heparan sulphate with which gC interacts are limited or inaccessible. The latter point follows if gB and gC interact with different structural features of heparan sulphate, which may be present in different concentrations on different cell types. Several lines of evidence support this notion. First, gC-dependent binding and gC-independent binding show differential sensitivity to various inhibitors of viral binding, most notably neomycin and poly-•-lysine. These inhibit the binding of wild-type HSV-1 (KOS or Rev), but not the binding of gC-negative virus (HSV-1AgC2-3 or gC-3) to cells (B. C. Herold & P. G. Spear, unpublished results) .
Second, although both HSV-1 and HSV-2 require cell surface heparan sulphate for optimum binding and infectivity (WuDunn & Spear, 1989) , there is evidence that HSV-1 and HSV-2 bind with different efficiencies to different cell types (Vahlne et al., 1979 (Vahlne et al., , 1980 . Because HSV-2 strains are more resistant than HSV-I strains to inhibition by neomycin (Campadelli-Fiume et al., 1990; Langeland et al., 1990) , the possibility exists that binding of HSV-2 is, in general, more dependent on gB, and on a different class of heparan sulphate structures, than the binding of HSV-1.
Third, Sears et al. (1991) found that wild-type and gCnegative strains differentially infect the apical and basolateral surfaces of polarized MDCK canine kidney cells. In their study, wild-type virus was found to be able to infect cells from both the apical and basolateral surfaces, whereas a gC-negative strain was only able to infect cells from the basolateral surface. One interpretation of these findings is that the structural features of heparan sulphate with which gB interacts (and hence, gC-negative viruses) are prevalent on the basolateral surface, whereas those with which gC interacts are present on both surfaces or only on the apical surface.
Heparan sulphate glycosaminoglycans are heterogeneous, varying in size, relative degrees of sulphation, and relative proportions of iduronic acid or glucuronic acid. Therefore it would not be surprising that different subpopulations of heparan sulphate might be present in different distributions on various cell types. The notion that different cell types express various kinds of heparan sulphate might explain, for example, why bFGF can inhibit HSV infection of certain cell types, but not others (Kaner et al., 1990; Mirda et al., 1992; Muggeridge et al., 1992) . The bFGF protein binds heparin and may inhibit HSV infection of cells where it competes with HSV for specific structural features of heparan sulphate.
It is possible that gB interacts with even more highly sulphated regions of heparan sulphate than gC. Alterations in sulphation of cell surface heparan sulphate, either by growth of cells in sodium chlorate or by genetic mutation, render cells partially resistant to HSV infection (Shieh et al., 1992) . Mutants that are gC-negative and dependent on gB for binding appear to be more sensitive than wild-type strains to alterations in sulphation. Further studies are in progress to delineate the structural features of heparan sulphate with which gC and gB interact. If the interaction of gB with heparan sulphate is important only when gC is absent, or when receptors for gC are limiting, then the heparan sulphate-binding roles of gB and gC are somewhat redundant, but may facilitate the ability of HSV to infect a variety of cells.
In addition to interacting with different structural features of heparan sulphate, gB and gC may also bind to heparan sulphate with different avidity. This follows from the observation that, once bound, only gC-positive virions are readily eluted by heparin washes, although neither gC-positive nor gC-negative virions are eluted by washes with PBS. This is quite distinct from the binding of PRV gC-negative virions, which, in addition to showing reduced specific binding, are readily eluted by washes with both PBS or soluble heparin (Karger & Mettenleiter, 1993) .
Although gB is able to mediate virus binding, at least when gC is absent, gB is also known to be required for viral penetration and for HSV-induced cell fusion Sarmiento et al., 1979; Manservigi et al., 1977) , whereas gC is dispensable for these two processes (Homa et al., 1986; Manservigi et al., 1977) . Recent results show that cell surface heparan sulphate is important for the activation of HSV-induced cell fusion (Shieh & Spear, 1994) as well as for the binding of virus to cells. Specifically, CHO cells transfected with the DNA of a gC-negative syncytial strain, HSV-1 (MP), were shown to undergo fusion only if the cells expressed heparan sulphate, or if exogenous heparin was added. Therefore the possibility exists that the interaction of gB with heparan sulphate is important in part for its contribution toward activation of membrane fusion.
The interactions of gC and gB with cell surface heparan sulphate are clearly not sufficient for the entry of HSV into cells. There is evidence that gD may interact with its own cell surface receptor (Johnson et al., 1990; Johnson & Ligas, 1988) . Oligomers of gH and gL, in addition to gB and gD, are also known to be required for HSV penetration Forrester et al., 1992; Roop et al., 1993; Ligas & Johnson, 1988) . In addition, the extent to which heparan sulphate is required for the binding of HSV to cells may be cell-dependent. For example, cell mutations that block heparan sulphate biosynthesis result in greater resistance of CHO cells to HSV infection (Shieh et al., 1992) than of mouse L cells (Gruenheid et al., 1993) .
Studies with other alphaherpesviruses, most notably PRV and BHV-1, indicate similar roles in infectivity for the glycoproteins homologous to HSV gB, gC, gD, gH and gL (Spear, 1993) . In fact, the gC homologue of PRV can at least partially complement a gC-deficient strain of BHV-1 (Liang et al., 1991b) . Similarly, PRV mutants lacking the essential glycoprotein B can be complemented by gB of BHV-t (Rauh et al., 1991) and HSV mutants lacking gB can be complemented by gB of PRV (Mettenleiter & Spear, 1994) . Moreover, expression of BHV-1 gB in a recombinant HSV that expresses the gB genes of both HSV and BHV-1 allows the recombinant virus to escape inhibition of infection by neutralizing antibodies specific for HSV gB (Misra & Blewett, 1991) . HSV gB can bind to heparin-Sepharose columns independently of HSV gC (Herold et al., 1991) , whereas PRV gB appears to bind to heparin-Sepharose only in the presence of PRV gC (Mettenleiter et al., 1990; Sawitzky et al., 1990) . This latter result suggests the possibility that the interaction of heparan sulphate with PRV gB may be less important to PRV infection than the interaction of heparan sulphate with HSV gB is to HSV infection.
It is tempting, but not yet feasible, to outline a specific sequence of events culminating in viral penetration. In most cases, it appears that the first step involves interactions of gC with cell surface heparan sulphate, but presumably there are circumstances where gB can mediate binding. Interactions of gB with heparan sulphate and perhaps other cell surface molecules and of the other HSV glycoproteins with unidentified cell components may then lead to the triggering of membrane fusion. How essential these interactions are, and whether they occur sequentially or simultaneously, is not yet known. It is possible that different interactions predominate depending on the viral strain and cell type. Generation and analysis of additional mutants, both viral and cellular, will be necessary to characterize viral entry further and to define the steps in what may be an orderly sequence of events that allows HSV efficiently to infect a wide range of cell types.
